Intertek Aktie 1428658 / GB0031638363
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
15.06.2026 15:12:35
|
Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
|
The Vanguard Group, Inc. ( )
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors’ and other employee options)
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
(b) Cash-settled derivative transactions
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
(ii) Exercise
(d) Other dealings (including subscribing for new securities)
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
(b) Agreements, arrangements or understandings relating to options or derivatives
(c) Attachments
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. View original content: EQS News |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Category Code: | RET - Intertek Group plc |
| TIDM: | |
| LEI Code: | 5493002789CX3L0CJP65 |
| Sequence No.: | 431702 |
| EQS News ID: | 2346320 |
| End of Announcement | EQS News Service |
|
|
Trading Signals: BB Biotech: Comeback nimmt Fahrt auf
Der heimische Biotech-Investor überzeugt nicht nur mit starken Quartalszahlen: Auch schlägt das Portfolio den Branchenindex deutlich, während die Aktie dem inneren Wert noch hinterherhinkt. Genau darin liegt weiteres Kurspotenzial.
Weiterlesen!Nachrichten zu Intertek plc
|
07.08.26 |
Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc (EQS Group) | |
|
06.08.26 |
Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc (EQS Group) | |
|
05.08.26 |
Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc (EQS Group) | |
|
04.08.26 |
Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc (EQS Group) | |
|
03.08.26 |
Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc (EQS Group) | |
|
03.08.26 |
FTSE 100-Wert Intertek-Aktie: So viel hätten Anleger mit einem Investment in Intertek von vor einem Jahr verdient (finanzen.ch) | |
|
31.07.26 |
Form 8.3 - The Vanguard Group, Inc.: Intertek Group PLC (EQS Group) | |
|
30.07.26 |
Form 8.3 - The Vanguard Group, Inc.: Intertek Group PLC (EQS Group) |
Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio
Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside ETF
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI geht etwas fester ins Wochenende -- DAX schliesst höher - neues Allzeithoch -- US-Handel endet mit Aufschlägen -- Asiens Börsen letztlich mehrheitlich mit GewinnenDer heimische Aktienmarkt bewegte sich am Freitag auf grünem Terrain. Der deutsche Leitindex konnte neue Höchststände erklimmen. An den US-Börsen dominierten die Käufer. Die Börsen in Fernost tendierten zum Wochenschluss überwiegend im Plus.


